3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Lymphoma
3
Neuroblastoma
2
Myelodysplastic Syndromes
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Influenza, Human
2
Skin Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Older Patients
1
Multiple Myeloma
1
Metabolic Diseases
1
Mesothelioma, Malignant
1
Mesothelioma
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Immunologic Deficiency Syndromes
1
Hodgkin Disease
1
Hepatoblastoma
1
Ganglioneuroblastoma
1
Interventions
Influenza Vaccines
2
Cyclophosphamide
2
thymoglobulin
1
fludarabine
1
baloxavir
1
Rituximab
1
Oseltamivir
1
Melphalan
1
Levetiracetam
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Diphtheria-Tetanus Vaccine
1
COVID-19 Vaccines
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Influenza, Human
×
Influenza Vaccines
×
1 year
×
Clear all
NCT06605625
2025-10-28
VRiC
Abramson Cancer Center at Penn Medicine
Active not recruiting
250 enrolled
NCT03955991
2025-06-26
VSMART
University of Miami
Phase 4
Completed
109 enrolled